{"transactions":[{"id":2450950,"issuer":{"id":112383,"kind":"organization","name":"Ampio Pharmaceuticals, Inc.","symbol":"AMPE"},"owners":[{"id":131757,"kind":"person","name":"MACALUSO MICHAEL","position":1,"cik":"0001096423","reported_name":"MACALUSO MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-04T18:31:41.000Z","date":"2022-01-01","kind":"tax_withholding","acquired":false,"shares":68400,"price":0.57,"value":38988.0,"ownership":{"direct":true},"balance_after":2624882,"source":{"system":"sec-edgar","filing":"0001415889-22-000257","document":"form4-01042022_030149.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1096423/000141588922000257/form4-01042022_030149.xml","form_type":"4"}},{"id":2533015,"issuer":{"id":112383,"kind":"organization","name":"Ampio Pharmaceuticals, Inc.","symbol":"AMPE"},"owners":[{"id":131757,"kind":"person","name":"MACALUSO MICHAEL","position":1,"cik":"0001096423","reported_name":"MACALUSO MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-10-28T20:30:04.000Z","date":"2021-10-27","kind":"tax_withholding","acquired":false,"shares":43470,"price":1.64,"value":71290.8,"ownership":{"direct":true},"balance_after":2693282,"source":{"system":"sec-edgar","filing":"0001415889-21-005016","document":"form4-10282021_051048.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1096423/000141588921005016/form4-10282021_051048.xml","form_type":"4"}},{"id":2543813,"issuer":{"id":112383,"kind":"organization","name":"Ampio Pharmaceuticals, Inc.","symbol":"AMPE"},"owners":[{"id":131757,"kind":"person","name":"MACALUSO MICHAEL","position":1,"cik":"0001096423","reported_name":"MACALUSO MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-10-13T19:37:35.000Z","date":"2021-10-11","kind":"grant","acquired":true,"shares":950000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2736752,"source":{"system":"sec-edgar","filing":"0001415889-21-004870","document":"form4-10132021_041029.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1096423/000141588921004870/form4-10132021_041029.xml","form_type":"4"}},{"id":2747608,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":131757,"kind":"person","name":"MACALUSO MICHAEL","position":1,"cik":"0001096423","reported_name":"MACALUSO MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-16T16:55:50.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":187804,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares. The restricted shares have the following accelerated vesting conditions: (1) The consummation of a Sale Event. (2) The closing price of the Company's stock price is equal or greater than forty dollars per share ($40) for two consecutive trading days. (3) The Grantee's service with the Company or a Related Entity is terminated by the Company without Cause (as defined below).The restricted shares vest as follows, and have no voting or dispositive rights until vested:  1/3 on April 16, 2022, and 1/12 on the first day of each quarter thereafter, such that the restricted shares will be fully vested on the third anniversary of the grant, subject to the reporting person's continuing employment with the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Grant of restricted shares. The restricted shares have the following accelerated vesting conditions: (1) The consummation of a Sale Event. (2) The closing price of the Company's stock price is equal or greater than forty dollars per share ($40) for two consecutive trading days. (3) The Grantee's service with the Company or a Related Entity is terminated by the Company without Cause (as defined below).The restricted shares vest as follows, and have no voting or dispositive rights until vested:  1/3 on April 16, 2022, and 1/12 on the first day of each quarter thereafter, such that the restricted shares will be fully vested on the third anniversary of the grant, subject to the reporting person's continuing employment with the Issuer."}],"balance_after":208079,"source":{"system":"sec-edgar","filing":"0001567619-21-008232","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1096423/000156761921008232/doc1.xml","form_type":"4"}},{"id":2936633,"issuer":{"id":112383,"kind":"organization","name":"Ampio Pharmaceuticals, Inc.","symbol":"AMPE"},"owners":[{"id":131757,"kind":"person","name":"MACALUSO MICHAEL","position":1,"cik":"0001096423","reported_name":"MACALUSO MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-21T18:36:55.000Z","date":"2020-12-17","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":1.78,"exercise_date":"2020-12-17","expiration_date":"2030-12-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-20-003005","document":"form4-12212020_031245.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1096423/000141588920003005/form4-12212020_031245.xml","form_type":"4"}},{"id":3089464,"issuer":{"id":112383,"kind":"organization","name":"Ampio Pharmaceuticals, Inc.","symbol":"AMPE"},"owners":[{"id":131757,"kind":"person","name":"MACALUSO MICHAEL","position":1,"cik":"0001096423","reported_name":"MACALUSO MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-06T15:00:00.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":255000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the stock options award vests and becomes exercisable on the date of the grant."}],"balance_after":255000,"derivative":{"exercise_price":0.65,"expiration_date":"2030-07-01","underlying":"Common Stock","underlying_shares":255000},"source":{"system":"sec-edgar","filing":"0001415889-20-001832","document":"form4-07062020_110748.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1096423/000141588920001832/form4-07062020_110748.xml","form_type":"4"}},{"id":3089463,"issuer":{"id":112383,"kind":"organization","name":"Ampio Pharmaceuticals, Inc.","symbol":"AMPE"},"owners":[{"id":131757,"kind":"person","name":"MACALUSO MICHAEL","position":1,"cik":"0001096423","reported_name":"MACALUSO MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-06T15:00:00.000Z","date":"2020-07-01","kind":"disposition_to_issuer","acquired":false,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was cancelled by mutual agreement between the company and the reporting person."}],"balance_after":0,"derivative":{"exercise_price":1.7,"expiration_date":"2020-08-27","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001415889-20-001832","document":"form4-07062020_110748.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1096423/000141588920001832/form4-07062020_110748.xml","form_type":"4"}},{"id":3089462,"issuer":{"id":112383,"kind":"organization","name":"Ampio Pharmaceuticals, Inc.","symbol":"AMPE"},"owners":[{"id":131757,"kind":"person","name":"MACALUSO MICHAEL","position":1,"cik":"0001096423","reported_name":"MACALUSO MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-06T15:00:00.000Z","date":"2020-07-01","kind":"disposition_to_issuer","acquired":false,"shares":220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was cancelled by mutual agreement between the company and the reporting person."}],"balance_after":0,"derivative":{"exercise_price":1.03,"expiration_date":"2020-08-12","underlying":"Common Stock","underlying_shares":220000},"source":{"system":"sec-edgar","filing":"0001415889-20-001832","document":"form4-07062020_110748.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1096423/000141588920001832/form4-07062020_110748.xml","form_type":"4"}},{"id":3112321,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":131757,"kind":"person","name":"MACALUSO MICHAEL","position":1,"cik":"0001096423","reported_name":"MACALUSO MICHAEL","relationship":{"director":true}}],"security":"Employee Stock Option Grant","published_at":"2020-06-12T17:41:41.000Z","date":"2020-06-08","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% vest on June 7, 2021, subject to the Grantee's continued service as a director on such dates."}],"balance_after":40105,"derivative":{"exercise_price":1.45,"expiration_date":"2030-06-07","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001654954-20-006581","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1096423/000165495420006581/section16.xml","form_type":"4"}},{"id":3311899,"issuer":{"id":112383,"kind":"organization","name":"Ampio Pharmaceuticals, Inc.","symbol":"AMPE"},"owners":[{"id":131757,"kind":"person","name":"MACALUSO MICHAEL","position":1,"cik":"0001096423","reported_name":"MACALUSO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Option (Right to Buy)","published_at":"2020-01-14T16:12:20.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Stock Option grant was awarded in connection with an employment agreement between the Reporting Person and the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of the Stock Option award vests and becomes exercisable on the date of the grant; the remaining 50% of the stock option award vests and becomes exercisable on January 10, 2021."}],"balance_after":200000,"derivative":{"exercise_price":0.6779,"exercise_date":"2020-01-10","expiration_date":"2030-01-10","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001415889-20-000097","document":"form4-01142020_010106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1096423/000141588920000097/form4-01142020_010106.xml","form_type":"4"}},{"id":3782512,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":131757,"kind":"person","name":"MACALUSO MICHAEL","position":1,"cik":"0001096423","reported_name":"MACALUSO MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-26T19:56:56.000Z","date":"2018-10-24","kind":"grant","acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted shares which vest on October 24, 2028, subject to earlier vesting in certain situations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Aggregate amount indicated reflects 20-for-1 reverse split and includes additional 2,663 post-split restricted shares previously issued."}],"balance_after":202738,"source":{"system":"sec-edgar","filing":"0001213900-18-014539","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1096423/000121390018014539/ownership.xml","form_type":"4"}},{"id":4167978,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":131757,"kind":"person","name":"MACALUSO MICHAEL","position":1,"cik":"0001096423","reported_name":"MACALUSO MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-09T19:02:40.000Z","date":"2017-11-07","kind":"grant","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted shares that vest on November 7, 2027, subject to earlier vesting in certain situations."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted shares that vest on November 7, 2027, subject to earlier vesting in certain situations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of these shares, 3,250 are restricted shares that vest on July 7, 2026, subject to earlier vesting in certain situations."}],"balance_after":54739,"source":{"system":"sec-edgar","filing":"0001213900-17-011712","document":"f4110717macaluso_aytubio.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1096423/000121390017011712/f4110717macaluso_aytubio.xml","form_type":"4"}},{"id":4380717,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":131757,"kind":"person","name":"MACALUSO MICHAEL","position":1,"cik":"0001096423","reported_name":"MACALUSO MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Grant","published_at":"2017-03-17T16:27:23.000Z","date":"2017-03-16","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These six transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. These options are 100% vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% vests on September 30, 2016, December 31, 2016, March 31, 2017 and June 30, 2017, subject to the Grantee's continued service as an employee on such dates."}],"balance_after":22500,"derivative":{"exercise_price":0.82,"expiration_date":"2026-07-07","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001638599-17-000299","document":"doc4_4627.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1096423/000163859917000299/doc4_4627.xml","form_type":"4"}},{"id":4380716,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":131757,"kind":"person","name":"MACALUSO MICHAEL","position":1,"cik":"0001096423","reported_name":"MACALUSO MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Grant","published_at":"2017-03-17T16:27:23.000Z","date":"2017-03-16","kind":"grant","acquired":true,"shares":8334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These six transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. These options are 100% vested."}],"balance_after":8334,"derivative":{"exercise_price":0.82,"exercise_date":"2016-04-11","expiration_date":"2026-04-11","underlying":"Common Stock","underlying_shares":8334},"source":{"system":"sec-edgar","filing":"0001638599-17-000299","document":"doc4_4627.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1096423/000163859917000299/doc4_4627.xml","form_type":"4"}},{"id":4380715,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":131757,"kind":"person","name":"MACALUSO MICHAEL","position":1,"cik":"0001096423","reported_name":"MACALUSO MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Grant","published_at":"2017-03-17T16:27:23.000Z","date":"2017-03-16","kind":"grant","acquired":true,"shares":10417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These six transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. These options are 100% vested."}],"balance_after":10417,"derivative":{"exercise_price":0.82,"exercise_date":"2015-11-11","expiration_date":"2025-11-11","underlying":"Common Stock","underlying_shares":10417},"source":{"system":"sec-edgar","filing":"0001638599-17-000299","document":"doc4_4627.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1096423/000163859917000299/doc4_4627.xml","form_type":"4"}},{"id":4380714,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":131757,"kind":"person","name":"MACALUSO MICHAEL","position":1,"cik":"0001096423","reported_name":"MACALUSO MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Grant","published_at":"2017-03-17T16:27:23.000Z","date":"2017-03-16","kind":"disposition_to_issuer","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These six transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. These options are 100% vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% vests on September 30, 2016, December 31, 2016, March 31, 2017 and June 30, 2017, subject to the Grantee's continued service as an employee on such dates."}],"balance_after":0,"derivative":{"exercise_price":3.23,"expiration_date":"2026-07-07","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001638599-17-000299","document":"doc4_4627.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1096423/000163859917000299/doc4_4627.xml","form_type":"4"}},{"id":4380713,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":131757,"kind":"person","name":"MACALUSO MICHAEL","position":1,"cik":"0001096423","reported_name":"MACALUSO MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Grant","published_at":"2017-03-17T16:27:23.000Z","date":"2017-03-16","kind":"disposition_to_issuer","acquired":false,"shares":8334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These six transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. These options are 100% vested."}],"balance_after":0,"derivative":{"exercise_price":3.23,"exercise_date":"2016-04-11","expiration_date":"2026-04-10","underlying":"Common Stock","underlying_shares":8334},"source":{"system":"sec-edgar","filing":"0001638599-17-000299","document":"doc4_4627.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1096423/000163859917000299/doc4_4627.xml","form_type":"4"}},{"id":4380712,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":131757,"kind":"person","name":"MACALUSO MICHAEL","position":1,"cik":"0001096423","reported_name":"MACALUSO MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Grant","published_at":"2017-03-17T16:27:23.000Z","date":"2017-03-16","kind":"disposition_to_issuer","acquired":false,"shares":10417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These six transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. These options are 100% vested."}],"balance_after":0,"derivative":{"exercise_price":3.23,"exercise_date":"2015-11-11","expiration_date":"2025-11-11","underlying":"Common Stock","underlying_shares":10417},"source":{"system":"sec-edgar","filing":"0001638599-17-000299","document":"doc4_4627.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1096423/000163859917000299/doc4_4627.xml","form_type":"4"}},{"id":4389376,"issuer":{"id":112383,"kind":"organization","name":"Ampio Pharmaceuticals, Inc.","symbol":"AMPE"},"owners":[{"id":131757,"kind":"person","name":"MACALUSO MICHAEL","position":1,"cik":"0001096423","reported_name":"MACALUSO MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-13T17:31:27.000Z","date":"2017-03-09","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"133,333 shares subject to the Option will vest and become exercisable on each of January 9, 2018 and January 9, 2019 and 133,334 shares will vest and become exercisable on January 9, 2020, subject to the Reporting Person's continuous service to the Issuer on each such date, and the terms under the Company's 2010 Stock Option and Incentive Plan and an employment agreement between the Reporting Person and the Issuer."}],"balance_after":400000,"derivative":{"exercise_price":0.81,"expiration_date":"2027-03-09","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001209191-17-020257","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1096423/000120919117020257/doc4.xml","form_type":"4"}}]}